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Abstract
Background: Estrogens control multiple functions of hormone-responsive breast cancer cells. They regulate diverse
physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation
or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process
underlying the onset and progress of the majority of breast cancer. ERa requires distinct co-regulator or
modulators for efficient transcriptional regulation, and they form a regulatory network. Knowing this regulatory
network will enable systematic study of the effect of ERa on breast cancer.
Methods: To investigate the regulatory network of ERa and discover novel modulators of ERa functions, we
proposed an analytical method based on a linear regression model to identify translational modulators and their
network relationships. In the network analysis, a group of specific modulator and target genes were selected
according to the functionality of modulator and the ERa binding. Network formed from targets genes with ERa
binding was called ERa genomic regulatory network; while network formed from targets genes without ERa
binding was called ERa non-genomic regulatory network. Considering the active or repressive function of ERa,
active or repressive function of a modulator, and agonist or antagonist effect of a modulator on ERa, the
ERa/modulator/target relationships were categorized into 27 classes.
Results: Using the gene expression data and ERa Chip-seq data from the MCF-7 cell line, the ERa genomic/non-
genomic regulatory networks were built by merging ERa/ modulator/target triplets (TF, M, T), where TF refers to the
ERa, M refers to the modulator, and T refers to the target. Comparing these two networks, ERa non-genomic network
has lower FDR than the genomic network. In order to validate these two networks, the same network analysis was
performed in the gene expression data from the ZR-75.1 cell. The network overlap analysis between two cancer cells
showed 1% overlap for the ERa genomic regulatory network, but 4% overlap for the non-genomic regulatory network.
Conclusions: We proposed a novel approach to infer the ERa/modulator/target relationships, and construct the
genomic/non-genomic regulatory networks in two cancer cells. We found that the non-genomic regulatory
network is more reliable than the genomic regulatory network.
Background
Nuclear receptors (NR) are a superfamily of ligand-
activated transcription factors that modulate specific gene
expression by interacting with specific DNA sequence
upstream of their target gene. So far there are over 100
nuclear receptors identified [1-3]. Estrogen receptor (ER)
is a member of the nuclear receptor superfamily and is
categorized into the class of ligand-dependent steroid
receptor in the 1960s. The study explained it controls
diverse biological processes by mediating the actions of
steroid hormone estrogen and afforded an appreciation of
its global importance in cell growth, cellular signalling, dif-
ferentiation, maturation and homeostasis in eukaryotic
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cells. Finally, the general pathway for steroid hormone
action was subsequently elucidated [4].
Unlike conventional transcription factors, ER is com-
posed of several domains including ligand binding, DNA
binding, dimerization, and transcriptional activation. The
ligand binding domain participates in several activities
including hormone binding, homo- and/or heterodimeri-
zation, and transcriptional activation and repression. The
binding of the estrogen induces conformational changes
in ER that could regulate gene expression by directed
interaction with DNA (genomic pathway of ER action) or
via an undirected connection with the modulation of
some specific proteins (non-genomic pathway) [5,6].
In a gene regulatory network, gene transcription varia-
tions are controlled by many transcription factors. It has
been established that the presence of regulatory sequences
is in the proximity of genes and the existence of proteins
is able to bind to those elements and to control the activity
of genes by either activation or repression of transcription
[7]. To understand gene regulation, the inference of its
regulatory network is an important research topic [8].
Recent genomic technology, such as genome wide expres-
sion array or sequencing, allows us to elucidate the global
gene regulatory mechanisms. Due to the well-developed
microarray technology, the wealthy information for gene
expression allows us to observe the expression levels of
thousand of gene at once and helps more accurately pre-
dict gene-to-gene interaction according to its similarity or
dissimilarity.
One approach to establish the gene regulatory network
is to start from gene-gene correlations or interactions.
Many computational approaches have been developed
aimed to measure associations between mRNA abundant
profiles to predict the transcriptional regulatory interac-
tion. Some attempts at determining gene regulation
based on the gene expression clustering algorithm. They
group the genes that show similar gene expression using
correlation coefficient matrix [9] or mutual information-
based algorithm [10,11] under the same condition [8,9].
However, clustering the resembling genes that are co-
regulated cannot present much more information about
the biological mechanisms of gene regulation or regula-
tory pathway. Thus, some computational algorithms are
proposed to reconstruct the gene networks by applying
statistical approaches, such as Relevance Network, Baye-
sian Network, Linear Regression Network [12], and our
own Regulation Network [3].
Relevance Network detects the relatedness between
two genes from their gene expression profiles and gives a
link between transcription factor and its target gene if
correlated [13-17]. The typical methods to calculate the
relatedness are Pearson Correlation Coefficient and
Mutual information. Pearson Correlation Coefficient pro-
vides better performance on detecting linear relationships
but it is not as intuitive as the Euclidean distance mea-
sure [17]. Mutual information (MI) gives good perfor-
mance on non-linear relationship. For example,
ARACNE algorithm [16] estimates the mutual informa-
tion between the gene expressions of two genes using
Gaussian kernel estimator. The measure of relatedness
by MI ranges from 0 to 1. Relevance network is a rela-
tively simple model, which computes the pair-wise simi-
larity or dissimilarity between two genes.
Bayesian Network (BN) can identify casual relation-
ships between variables. The topology a BN can provide
the dependence or independence of variable [18], BN
algorithm can reveal the dynamics of the gene regulation
hierarchy. While BN has its advantage of structure
model, it is difficult to inform whether a node (gene) is
important to be included. Another challenging is its com-
putational stability. It usually results in multiple optimal
networks [19]. The high computational requirement
leads to almost impossible of inference to a large-scale
regulatory network [20]. Also, BN assumes no gene-gene
interaction, which can misrepresent the data.
Our proposed ERa regulatory network is a combina-
tion of TF binding affinity estimated from ChIP-seq
data, up or down regulation using gene expression, and
motif conservation in probe sequences. This approach
effectively utilized the genomic or non-genomic actions.
Unlike previous regression approaches, this method did
not use correlation information.
In this paper, our proposed approach analyzes the inter-
action between TF and target gene conditioned on a
group of specific modulator genes. Also, we consider the
change of modulators’ expression level to perceive its
influence on transcriptional activity. We reconstruct gene
regulatory networks in related biological subjects via a
multiple linear regression approach with interaction term
such that the inferred modulator gene is directly embodied
and the relationships of the biological subjects they repre-
sent are easily exploited. As a result, this reveals deeper
insight on how the structure, function, and behaviour of
components evolve.
Method
mRNA gene expression profiling data preprocessing
mRNA expression profiling for ERa was performed as
previously described [2]. The microarray data for ERa in
MCF-7 and ZR-75.1 cells treated with E2 were obtained
from Experiment E-TABM-742 (http://www.ebi.ac.uk/
arrayexpress/experiments/E-TABM-742). In this dataset,
gene expression profile of human estrogen-responsiveb-
breast cancer cell lines ZR-75.1 and MCF-7 treated with
10-8 M of 17 b-estradiol (E2) on total RNA extracted
before or after 1, 2, 4, 6, 8, 12, 16, 20, 24, 28 and 32 hours
hormonal stimulation. The microarray data were prepro-
cessed by BeadStudio Software version 3.2 with quantile
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normalization. Data were log2 transformed and the ratio
of each signal against average reference signal were calcu-
lated [2]. There are 48702 probes in total.
More quality control analyses were performed. A
probe is considered as absent if it is called absent in
every time point by the BeadStudio Software, and these
absent probes were excluded. Then, gene expression
was averaged from the existing duplicate present probes.
Genes with the small coefficient of variance are also
removed. Using the threshold of 0.15, there were 6418
genes in MCF-7 cell and 13872 genes for ZR-75.1 cell
left for the network analysis.
ChIP-seq data analysis
ERa ChIP-seq data were prepared by Tim H. M. Huang’s
lab and generated for MCF-7 cell before and after E2
treatment 0.5, 1, and 24 hours. Sequencing was con-
ducted with Illumina Genome Analyzer II (GA II) as per
manufacturer’s instructions. Reads are organized into a
contiguous assembly of 24 different strands (one for each
chromosome) and mapped to human genome reference
sequence (HG18) using ELAND provided by Illumina.
Four published peak-calling algorithms were applied to
call the ERa binding sites: including CisGenome [21],
GeneTrack [22], MACS [23], and SISSRS [24] with FDR
= 0.001 to predict ERa binding peaks.
Linear regression model with interaction term
A linear regression model (1), with an interaction term
is constructed to describe the relationship among TF
(ERa), M (modulator), and T (target).
T = a1 + a2M + b1TF + b2TF × M + ε, (1)
where (TF, T) are all J×1 vectors gene expression, and J
is the total sampling time of gene expression samples; M
is a binary variable (0 means low, and 1 means high)
derived by the expression of a modulator’s expression
divided by its median; (a1, a2, b1, b2) are regression coef-
ficients. For parameter setting, we did try the continuous
scale for M at the beginning, and found that it often
times it was highly sensitive to its skewed distribution
because of small sample size. Therefore, a binary M is
more robust choice. When the expression of modulator
is high (M = 1), Eq. (1) becomes T = (a1 + a2) + (b1 + b2)
TF; otherwise, T = a1 +b1TF when M = 0. Parameter b2
presents the change of T in response to TF influenced
by M. If b2 is not statistically significant, the data do not
have enough evidence to support M modulates the TF’s
effect on the target T.
Schematic representation
Using a linear regression model with the interaction
term, the regression coefficients (a2, b1, b2) define the
functional relationship of the triplicate (T, TF, M).
Eq. (2) defines the correlation indicator for all three
regression parameters for any triplicate data analysis.




+, significant with positive value
−, significant with negative value
0, not significant
(2)
A schematic overview of the triplicate network is
shown in Figure 1. There are two lines between TF and
T. These two lines mean two types of network construc-
tion according to the rule of modulator in the network.
The solid line stands for the direct influence on the
relationship between TF and T, which is independent of
M; while the dashed line represents that the relationship
of TF on T depends on M. Based on the criterion of
correlation indicator (CI) described above, there are 27
categories of network behaviours from all combinations.
Modulator gene candidates
We focus our modulators on specific molecular func-
tional classes. Using Gene Ontology (GO) molecular
function, several functional classes are included: protein
kinase activity, phosphoprotein phosphatase activity,
acetyltransferase activity, deacetylase activity, methl-
transferase activity, transcription factors, and transcrip-
tional cofactors. In these 7 specific GO molecular
functions, 485 unique modulator genes are found from
the pool of 6418 presented genes in MCF-7 cell. The
result of GO analysis is shown in Table 1.
ERa genomic and non-genomic target gene selection
Using ChIP-seq analysis, only genes that have ERa bind-
ings at 0, 0.5, 1, and 24 hours are considered genomic
target. Four peak finding algorithms are used in predict-
ing the binding sites: CisGenome, GeneTrack, MACS,
and SISSRS with FDR = 0.001. Motif Conservation Score
(MCS) [25] of each binding site overlapping with the
Figure 1 Linear regression model. A schematic overview of the
triplicate network: Based on the criterion of correlation indicator (CI)
described above, there are 27 categories (TF/M/T relationships) of
network behaviours from all combinations.
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known genes from the 6418 gene profiles is calculated,
and a 95% conservation score is chosen as the threshold.
As a consequence, 56 genes appearing in the results of 4
diverse algorithms can regard as the reliable target gene
candidates in ERa genomic network. For the non-geno-
mic network, we didn’t treat all the other genes as non-
genomic targets. As a matter of fact, only genes who
don’t have any binding signals with all the ChIP-seq peak
finding tools in all four time points were selected as the
non-genomic targets. There are 5877 genes not appearing
in the results of 4 diverse algorithms.
Network construction
Using the triplicates generated from the linear model
with the interaction, a network model can be con-
structed. This initial network will include an enormous
amount of modulators which have only limited targets.
Therefore, a filtering threshold is developed to keep
only modulators with significant number of targets. In
this network analysis, all the connections among the
modulators, targets, and the TF are assumed at random,
though the total number of connections is fixed as the
observed number from our previous analysis. After 1000
times shuffling in the network connections, a distribu-
tion of target number of any modulator is formed, and
95% threshold is chosen for the modulator selection.
ERa regulatory network construction flowchart
The ERa regulatory network construction goes through
data pre-processing, modulator selection, genomic target/
non-target selection, linear regression with interaction,
and network construction. Figure 2 shows an integration
of analytic workflow for the proposed method.
Results
ERa/modulator categories
Using ChIP-seq data, we predicted 56 ERa genomic tar-
gets and 5877 non-genomic targets. Together with our
pre-specified modulators, we generated 22 (T, TF, M)
categories that involve the interactions with modulator
genes. Many categories have FDR < 10% in both geno-
mic and non-genomic (T, TF, M) categories. In particu-
larly, genomic regulatory categories have higher FDRs
than the non-genomic categories.
The following are four highlighted examples. Figure 3
(a,b) show the modulator genes mediated the transcrip-
tion activities, which enhance and repress the expression
level of their corresponding target genes. Figure 3(c,d)
illustrates that CDK6 possesses the indirect influence on
target genes according to the diverse level of its gene
expression. Figure 3(c) represents CDK6 is inferred as
an activator agonist of TF (ERa). Conventionally, ERa has
no function on target gene (LOC652683). When the
expression level of CDK6 comes to high, it stimulates ERa
to turn into an activator to target gene (LOC652683). On
the contrary, CDK6 owns the opposite capability to ERa
since TF which makes no impact on target gene (CHD9)
when CDK6 expression is high, which are illustrated in
the Figure 3(d). It is implicated that each modulator gene
can stimulate TF to either activate or repress a large num-
ber of targets, depending on the cellular context.
ERa regulatory network analysis
Once a biological process is represented by a network, the
analysis of network topology uncovers the functional orga-
nization and unknown organizing principles of cellular
systems [26]. Many network researches investigate net-
work activity for an active node by using the concept of
degrees, defined as the number of edges adjacent to the
neighbours. As a node has larger or higher connectivities,
Table 1 Gene ontology table for modulator genes
GO:ID # of unique
modulator
Signalling protein




Acetyltransferase activity GO:0016407 8
Deacetylase activity GO:0019213 1
Methltransferase activity GO:0008168 57
TF protein
Transcription factor activity GO:0030528 156
Transcription cofactor activity GO:0003712 58
Total 485
Figure 2 The analytic workflow of gene regulatory network
analysis. An integration of analytic workflow for the proposed
method is proposed. GRN construction goes through data pre-
processing, modulator selection, genomic target/non-target
selection, linear regression with interaction, and network
construction.
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it represents to be the important connector and has more
impact on the signalling pathway. For this reason, we
zoom in our scope into a small-scale ERa regulatory
networks.
To concentrate on those modulators with a large
number of targets, ERa regulatory networks are con-
structed from the triplicates from Table 2. The thresh-
olds on both MCF-7 and ZR-75.1cell were chosen based
Figure 3 Examples of the behavior of gene interaction. 4 highlight examples of inferred gene interactions. (a) and (b) shows the modulator
genes mediated the transcription activities, which enhance and repress the expression level of their corresponding target genes. (c) and (d) show
CDK6 possesses the indirect influence on target genes according to the diverse level of its gene expression, which stimulate the TF activity.
Table 2 Statistical results for modulator-TF-target Interaction
ERa genomic ERa non-genomic












1 TF (Ind. Activator) 0 + 0 - - - - - -
2 TF (Ind. Repressor) 0 - 0 - - - - - -
3 TF (Ind. Activator) and M (Ind. Activator) + + 0 58/21 67 34.870 367/2590 6447 1.906
4 TF (Ind. Repressor) and M (Ind. Activator) + - 0 0/0 0 NA 0/0 0 NA
5 TF (Ind. Activator) and M (Ind. Repressor) - + 0 36/14 40 16.688 306/1035 3230 ~ 0
6 TF (Ind. Repressor) and M (Ind. Repressor) - - 0 0/0 0 NA 144/88 349 ~ 0
7 TF (Activator) and M (Agonist) 0 + + 185/21 307 14.133 419/2372 71465 0.587
8 TF (Activator) and M (Antagonist) 0 + - 282/47 908 3.676 470/4875 71166 0.824
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on the data itself, not on heuristics. A threshold of 18
targets for MCF-7 cell was chosen for modulator selec-
tion with a 0.1 level of FDR. Figure 4 and 5 visualize the
ERa genomic and non-genomic network. ERa genomic
regulatory network comprises of 85 modulators and 56
target genes. On the other hand, there are 25 modula-
tors and 87 target genes in ERa non-genomic network.
The gene marked with green rectangle represents modu-
lator gene and the gene with pink circle is target gene.
The size of rectangle or circle differentiates the degree
of connections. The red colour line stands for the inter-
action between modulator and transcription factor, and
blue line means the transcription activity between a pair
of genes.
Validation studies with ZR-75.1
In the previous studies [27,28], both ERa-positive, hor-
mone-responsive MCF-7 and ZR-75.1 cell had been well
established to investigate the molecular and genomic
mechanisms mediating hormonal control of cell function
in vitro. Evidences in literature showed that some known
genes in MCF-7 and ZR-75.1 cells are identified to have
identical kinetic and type of response to hormone in
breast cancer model after E2 stimulation. To investigate
the target genes whose expression profile were signifi-
cantly modified and the modulator genes who mediate
the transcription activities of ERa action, gene expression
data of ZR-75.1 was applied to our regulatory model to
validate the results of MCF-7. It yielded (47/4799) over-
lapped triplets for genomic network and (12/270) triplets
for non-genomic network, where 4799 and 270 are the
number of triplets from the results of MCF-7. Using
these overlapping triplets, ERa genomic/nongenomic
network are exhibited in Figure 6.
For the results of the overlapping networks, the statis-
tical significance of comparing the ERa network between
two cancer cells is not our primary interests. As we have
shown in our previous work, the overlap between the
two gene regulatory networks in two different time
points after E2 stimulation was very small even in a sin-
gle cell line. We don’t expect a significant overlap
between two networks between two cells. The simply
want to know what are the overlapped components and
non-overlapped components. This description itself is
very valuable. In addition, both GO and KEGG don’t
have estrogen signalling pathways, and we don’t feel
these analyses will add much to our understanding of
the estrogen regulatory network.
Conclusions
This paper proposed a regression model based approach
in ERa regulatory network model construction. It
Table 2 Statistical results for modulator-TF-target Interaction (Continued)
9 TF (Repressor) and M (Antagonist) 0 - + 94/2 96 0 258/206 5125 1.289
10 TF (Repressor) and M (Agonist) 0 - - 0/0 0 NA 0/0 0 NA
11 TF (Activator) and M (Agonist & Ind.
Activator)
+ + + 0/0 0 NA 0/0 0 NA
12 TF (Activator) and M (Antagonist & Ind.
Activator)
+ + - 284/51 849 1.572 477/5204 78213 0.206
13 TF (Repressor) and M (Antagonist & Ind.
Activator)
+ - + 0/0 0 NA 0/0 0 NA
14 TF (Repressor) and M (Agonist & Ind.
Activator)
+ - - 0/0 0 NA 0/0 0 NA
15 TF (Activator) and M (Agonist & Ind.
Repressor)
- + + 272/22 934 1.072 432/2171 51064 0.244
16 TF (Activator) and M (Antagonist & Ind.
Repressor)
- + - 0/0 0 NA 0/0 0 NA
17 TF (Repressor) and M (Antagonist & Ind.
Repressor)
- - + 23/2 26 12.837 332/442 8152 ~ 0
18 TF (Repressor) and M (Agonist & Ind.
Repressor)
- - - 0/0 0 NA 0/0 0 NA
19 M (Ind. Activator) + 0 0 - - - - - -
20 M (Ind. Repressor) - 0 0 - - - - - -
21 M (Activator Agonist) 0 0 + 261/37 835 4.797 418/3619 118241 0.479
22 M (Repressor Agonist) 0 0 - 42/8 65 15.404 213/977 5546 1.709
23 M (Activator Agonist & Ind. Activator) + 0 + 0/0 0 NA 0/0 0 NA
24 M (Repressor Agonist & Ind. Activator) + 0 - 23/9 34 19.633 354/1453 6119 0.951
25 M (Activator Agonist & Ind. Repressor) - 0 + 277/40 638 2.093 440/3852 80644 0.336
26 M (Repressor Agonist & Ind. Repressor) - 0 - 0/0 0 NA 0/0 0 NA
27 No Function 0 0 0 - - - - - -
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characterizes the interaction between ERa and its mod-
ulators and their associated gene targets. With addi-
tional ERa binding information from ChIP-seq data, we
are able to construct ERa genomic and non-genomic
regulatory models. Comparing these two networks, ERa
non-genomic network has lower FDR than the genomic
Figure 5 ERa non-genomic network. 25 selected modulator and 87 target genes constructed the ERa non-genomic network in MCF-7 cell.
Figure 4 ERa genomic network. 85 selected modulator and 56 target genes constructed the ERa genomic network in MCF-7 cell.
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Figure 6 Overlapping network between MCF-7 and ZR-75.1 cells. (a) shows the overlapping genomic network between two cell lines. It
consists 26 modulator and 71 target genes. (b) is the overlapping non-genomic network.
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network. This was validated by the same network analy-
sis on both ZR-75.1 and MCF-7 cells.
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